Plasmid pIMI38--the pBR322 derivative with increased stability in E. coli cells.
Plasmid pIM138 which had been characterized by the higher resistance of its DNA replication to the action of clorobiocin in comparison with the progenitor plasmid, was tested for its stability in host cells in the absence of the antibiotic. Growing without selective pressure, pIM138 was better maintained in cells than pBR322. The stability in the presence and in the absence of clorobiocin can be unanimously assigned to the plasmid itself, but some influence of host cells cannot be excluded.
D001483:Base Sequence; D004261:DNA Replication; D004269:DNA, Bacterial / Q000032:analysis / Q000378:metabolism*; D004926:Escherichia coli / Q000187:drug effects / Q000378:metabolism*; D008969:Molecular Sequence Data; D009675:Novobiocin / Q000031:analogs & derivatives / Q000494:pharmacology; D010957:Plasmids / Q000187:drug effects
D004269:DNA, Bacterial; D009675:Novobiocin; C006260:clorobiocin